IL153559A0 - Compounds for treating impaired fundic relaxation - Google Patents

Compounds for treating impaired fundic relaxation

Info

Publication number
IL153559A0
IL153559A0 IL15355901A IL15355901A IL153559A0 IL 153559 A0 IL153559 A0 IL 153559A0 IL 15355901 A IL15355901 A IL 15355901A IL 15355901 A IL15355901 A IL 15355901A IL 153559 A0 IL153559 A0 IL 153559A0
Authority
IL
Israel
Prior art keywords
compounds
treating impaired
fundic relaxation
impaired fundic
relaxation
Prior art date
Application number
IL15355901A
Other languages
English (en)
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of IL153559A0 publication Critical patent/IL153559A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D411/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IL15355901A 2000-06-22 2001-06-13 Compounds for treating impaired fundic relaxation IL153559A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00202180 2000-06-22
PCT/EP2001/006749 WO2001098306A1 (en) 2000-06-22 2001-06-13 Compounds for treating impaired fundic relaxation

Publications (1)

Publication Number Publication Date
IL153559A0 true IL153559A0 (en) 2003-07-06

Family

ID=8171674

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15355901A IL153559A0 (en) 2000-06-22 2001-06-13 Compounds for treating impaired fundic relaxation
IL153559A IL153559A (en) 2000-06-22 2002-12-19 Compounds for the treatment of defective fundus relaxation

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL153559A IL153559A (en) 2000-06-22 2002-12-19 Compounds for the treatment of defective fundus relaxation

Country Status (34)

Country Link
US (2) US7081453B2 (xx)
EP (1) EP1296987B1 (xx)
JP (1) JP4911860B2 (xx)
KR (1) KR100821107B1 (xx)
CN (2) CN1288157C (xx)
AR (1) AR032158A1 (xx)
AT (1) ATE312104T1 (xx)
AU (1) AU783292B2 (xx)
BG (1) BG65895B1 (xx)
BR (1) BR0111859B1 (xx)
CA (1) CA2410233C (xx)
CZ (1) CZ305005B6 (xx)
DE (1) DE60115647T2 (xx)
EA (1) EA005760B1 (xx)
EE (1) EE04878B1 (xx)
EG (1) EG24462A (xx)
ES (1) ES2254467T3 (xx)
HK (1) HK1057896A1 (xx)
HR (1) HRP20020988B1 (xx)
HU (1) HU227398B1 (xx)
IL (2) IL153559A0 (xx)
IS (1) IS2618B (xx)
JO (1) JO2352B1 (xx)
MX (1) MXPA02012844A (xx)
MY (1) MY155267A (xx)
NO (1) NO328547B1 (xx)
NZ (1) NZ522519A (xx)
PA (1) PA8519601A1 (xx)
PL (1) PL201656B1 (xx)
SA (1) SA01220442B1 (xx)
SK (1) SK287730B6 (xx)
UA (1) UA74576C2 (xx)
WO (1) WO2001098306A1 (xx)
ZA (1) ZA200210303B (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0011237A (pt) 1999-06-02 2002-03-05 Janssen Pharmaceutica Nv Derivados de benzodioxano, benzofurano ou benzopirano substituìdos com aminoalquila
JP2003501428A (ja) 1999-06-02 2003-01-14 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ ピロリジニル、ピペリジニルもしくはホモピペリジニル置換（ベンゾジオキサン、ベンゾフランもしくはベンゾピラン）誘導体
JO2352B1 (en) * 2000-06-22 2006-12-12 جانسين فارماسيوتيكا ان. في Compounds for the treatment of non-adaptation of the bottom of the uterus
JO2654B1 (en) * 2000-09-04 2012-06-17 شركة جانسين فارماسوتيكا ان. في Multiple aryl caroxa amides are useful as lipid - lowering agents
JO2409B1 (en) 2000-11-21 2007-06-17 شركة جانسين فارماسوتيكا ان. في Second-phenyl carboxy amides are useful as lipid-lowering agents
RU2379303C2 (ru) 2003-04-24 2010-01-20 Инсайт Корпорейшн Производные азаспироалканов в качестве ингибиторов металлопротеаз
JP4896476B2 (ja) * 2005-09-16 2012-03-14 広栄化学工業株式会社 メチルオキシメチルアミノピリジン誘導体及びその製造方法
US7999107B2 (en) 2007-01-31 2011-08-16 Merck Sharp & Dohme Corp. Substituted pyrano[2,3-B]pyridine derivatives as cannabinoid-1 receptor modulators
CA2685860A1 (en) * 2007-05-10 2008-11-20 Amr Technology, Inc. Aryl- and heteroaryl-substituted tetrahydrobenzo-1,4-diazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
CA2853024C (en) 2011-11-11 2017-08-22 Pfizer Inc. 2-thiopyrimidinones
PE20180503A1 (es) 2015-05-05 2018-03-09 Pfizer 2-tiopirimidinonas
CN105481839B (zh) * 2015-11-23 2018-05-11 安徽千和新材料科技发展有限公司 一种光活性环氧啉对映体的制备方法
EP3229193A1 (en) 2016-04-07 2017-10-11 The Boeing Company A computer-implemented method and system for sharing information between passengers and air traffic management stakeholders

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3910930A (en) 1973-01-04 1975-10-07 Janssen Pharmaceutica Nv 1-{55 1-{8 2-(1,4-Benzodioxan-2-yl)-2-hydroxyethyl{9 -4-piperidyl{56 -2-benzimidazolinones
DE2400049A1 (de) * 1974-01-02 1975-07-10 Spumalit Anstalt Transportkasten aus kunststoff, insbesondere fuer flaschen
GR71865B (xx) 1978-03-20 1983-07-07 Ciba Geigy
US4329348A (en) * 1979-02-26 1982-05-11 Ciba-Geigy Corporation N-Oxacyclic-alkylpiperidines as psychostimulants
DE3484096D1 (de) * 1983-11-30 1991-03-14 Janssen Pharmaceutica Nv Bizyklisches heterozyklyl aufveisende n-(bizyklisches heterozyklyl-4-piperidinamine.
SI9300097B (en) 1992-02-27 2001-12-31 Janssen Pharmaceutica Nv (benzodioxan, benzofuran or benzopyran) alkylamino) alkyl substituted guanidines
ZA931343B (en) 1992-03-06 1993-09-24 Akzo Nv 1,4-dioxino(2,3-b)pyridine derivatives.
US6403103B1 (en) * 1994-08-12 2002-06-11 Bio Merieux Trypanosoma cruzi antigen, gene encoding therefore, and methods of detecting and treating chagas disease
FR2744451B1 (fr) * 1996-02-01 1998-04-24 Pf Medicament Nouvelles imidazolidinones, pyrimidinones, et 1,3-diazepin-2 -ones, leur preparation et leurs applications en therapeutique
US6133277A (en) * 1997-12-05 2000-10-17 Janssen Pharmaceutica N.V. (Benzodioxan, benzofuran or benzopyran) derivatives having fundic relaxation properties
JP2003501428A (ja) 1999-06-02 2003-01-14 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ ピロリジニル、ピペリジニルもしくはホモピペリジニル置換（ベンゾジオキサン、ベンゾフランもしくはベンゾピラン）誘導体
BR0011237A (pt) 1999-06-02 2002-03-05 Janssen Pharmaceutica Nv Derivados de benzodioxano, benzofurano ou benzopirano substituìdos com aminoalquila
TWI225488B (en) * 1999-12-21 2004-12-21 Janssen Pharmaceutica Nv Derivatives of homopiperidinyl substituted benzimidazole analogues
JO2352B1 (en) * 2000-06-22 2006-12-12 جانسين فارماسيوتيكا ان. في Compounds for the treatment of non-adaptation of the bottom of the uterus

Also Published As

Publication number Publication date
CN1437602A (zh) 2003-08-20
BG65895B1 (bg) 2010-04-30
JO2352B1 (en) 2006-12-12
PA8519601A1 (es) 2002-08-26
EE04878B1 (et) 2007-08-15
DE60115647D1 (de) 2006-01-12
ES2254467T3 (es) 2006-06-16
EE200200694A (et) 2004-06-15
SA01220442B1 (ar) 2008-05-21
SK492003A3 (en) 2003-07-01
EP1296987A1 (en) 2003-04-02
BR0111859B1 (pt) 2015-01-06
NO20026219L (no) 2003-02-17
CA2410233C (en) 2011-01-25
AR032158A1 (es) 2003-10-29
US7081453B2 (en) 2006-07-25
JP4911860B2 (ja) 2012-04-04
CN1781921A (zh) 2006-06-07
DE60115647T2 (de) 2006-08-24
BR0111859A (pt) 2003-05-13
EG24462A (en) 2009-07-16
WO2001098306A1 (en) 2001-12-27
SK287730B6 (en) 2011-07-06
EP1296987B1 (en) 2005-12-07
BG107313A (bg) 2003-06-30
HRP20020988A2 (en) 2005-02-28
US20060142318A1 (en) 2006-06-29
IS2618B (is) 2010-04-15
IS6591A (is) 2002-10-25
KR20030007566A (ko) 2003-01-23
HU227398B1 (hu) 2011-05-30
EA200300049A1 (ru) 2003-04-24
AU783292B2 (en) 2005-10-13
HRP20020988B1 (en) 2011-06-30
CA2410233A1 (en) 2001-12-27
IL153559A (en) 2008-03-20
US7423048B2 (en) 2008-09-09
ATE312104T1 (de) 2005-12-15
UA74576C2 (en) 2006-01-16
MY155267A (en) 2015-09-30
JP2004501157A (ja) 2004-01-15
US20040019051A1 (en) 2004-01-29
CN100516066C (zh) 2009-07-22
PL201656B1 (pl) 2009-04-30
CN1288157C (zh) 2006-12-06
CZ2003115A3 (cs) 2003-06-18
NO328547B1 (no) 2010-03-15
AU8386401A (en) 2002-01-02
NO20026219D0 (no) 2002-12-23
EA005760B1 (ru) 2005-06-30
KR100821107B1 (ko) 2008-04-14
CZ305005B6 (cs) 2015-03-25
NZ522519A (en) 2003-09-26
HK1057896A1 (en) 2004-04-23
PL358886A1 (en) 2004-08-23
HUP0301185A3 (en) 2009-03-30
HUP0301185A2 (hu) 2003-08-28
ZA200210303B (en) 2004-03-19
MXPA02012844A (es) 2003-05-15

Similar Documents

Publication Publication Date Title
GB0028264D0 (en) Well treatment
GB0028269D0 (en) Well treatment
AU3097701A (en) Combinations for treating neoplasms
GB0004063D0 (en) Adjusting apparatus
EG25829A (en) Novel treatment
EP1254698A4 (en) OZONE PROCESSING APPARATUS
IL153559A0 (en) Compounds for treating impaired fundic relaxation
EP1267903A4 (en) METHODS OF TREATING GLAUCOMA
GB0118349D0 (en) Apparatus for treating objects
GB0030845D0 (en) Novel treatment
AU4498201A (en) Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment ofpain
HK1050897A1 (en) Pyranoindoles for treating glaucoma
SG89379A1 (en) Treatment apparatus
GB0007652D0 (en) Treatment for fabrics
HK1046848A1 (en) Specific therapeutic composition for treating aids
GB0026838D0 (en) Treatment method
PT1698338E (pt) S-metil-di-hidro-ziprasidona para o tratamento de distúrbios psiquiátricos
GB0027523D0 (en) Improved apparatus
GB0000442D0 (en) Web treatment
CA91213S (en) Rollator
GB0029125D0 (en) Novel treatment
AU1079402A (en) Wastewater treatment
TW479626U (en) Treatment device for junk
GB0007665D0 (en) Treatment for fabrics
GB2364528B (en) Sewage treatment apparatus

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed